05/12/2022
Review
Preclinical and clinical developments for combination treatment of influenza
In this Review, Koszalka and colleagues summarize preclinical and clinical advances in combination therapy for the treatment of influenza with reference to immunocompromised animal models and clinical data in hospitalized patient cohorts where available. They include polymerase inhibitors, monoclonal antibodies (mAbs), host-targeted therapies, and adjunctive therapies.
Image credit: Prawny, Pixabay
Connect with Us